These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade. Kantharia BK; Patel JA; Nagra BS; Ledley GS Europace; 2006 Aug; 8(8):625-8. PubMed ID: 16772367 [TBL] [Abstract][Full Text] [Related]
4. Unusual Incessant Ventricular Tachycardia: What Is the Underlying Cause and the Possible Mechanism? Shenthar J Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1507-11. PubMed ID: 26671936 [No Abstract] [Full Text] [Related]
5. Implantable cardioverter defibrillator therapy for ambulatory ventricular tachycardia: are we using an elephant gun? Kadish AH J Cardiovasc Electrophysiol; 2004 Jun; 15(6):665-6. PubMed ID: 15175061 [No Abstract] [Full Text] [Related]
7. An electrical storm with more than 3000 shocks in a patient with an implantable cardioverter-defibrillator: is jet-lag a trigger? Han SW; Kim YN; Lee YS; Hyun DW; Kim D; Hur SH; Kim KS; Kim KB Int J Cardiol; 2005 Sep; 104(2):235-7. PubMed ID: 16168822 [No Abstract] [Full Text] [Related]
10. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia. Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060 [TBL] [Abstract][Full Text] [Related]
11. The 1+1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias. Bänsch D; Steffgen F; Grönefeld G; Wolpert C; Böcker D; Mletzko RU; Schöls W; Seidl K; Piel M; Ouyang F; Hohnloser SH; Kuck KH Circulation; 2004 Aug; 110(9):1022-9. PubMed ID: 15326069 [TBL] [Abstract][Full Text] [Related]
12. Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators. Ermis C; Zhu AX; Vanheel L; Lemke MJ; Sakaguchi S; Lurie KG; Lu F; Lin J; Benditt DG Am J Cardiol; 2005 Jul; 96(2):233-8. PubMed ID: 16018849 [TBL] [Abstract][Full Text] [Related]
13. Delayed detection of ventricular tachycardia in a dual chamber rate adaptive pacing implantable cardioverter defibrillator: a case of intradevice interaction. Strohmer B Pacing Clin Electrophysiol; 2005 Jan; 28(1):76-7. PubMed ID: 15660811 [No Abstract] [Full Text] [Related]
14. Delayed detection of ventricular tachycardia in a dual chamber rate adaptive pacing implantable cardioverter defibrillator: a case of intradevice interaction. Shalaby AA Pacing Clin Electrophysiol; 2004 Aug; 27(8):1164-6. PubMed ID: 15305971 [TBL] [Abstract][Full Text] [Related]
15. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Sweeney MO Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472 [No Abstract] [Full Text] [Related]
16. Atrial diagnostics in a tiered therapy implantable defibrillator. Tang C; Schwartz M; Yeung-Lai-Wah JA Can J Cardiol; 1997 May; 13(5):446-8. PubMed ID: 9179082 [TBL] [Abstract][Full Text] [Related]
17. Conversion of Brugada type I to type III and successful control of recurrent ventricular arrhythmia with cilostazol. Ağaç MT; Erkan H; Korkmaz L Arch Cardiovasc Dis; 2014; 107(8-9):476-8. PubMed ID: 23791603 [No Abstract] [Full Text] [Related]
18. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator. Sinha AM; Stellbrink C; Schuchert A; Mox B; Jordaens L; Lamaison D; Gill J; Kaplan A; Merkely B; J Cardiovasc Electrophysiol; 2004 Jun; 15(6):646-52. PubMed ID: 15175058 [TBL] [Abstract][Full Text] [Related]
19. [Eleven-years long follow-up in a patient after myocardial infarction, with low ejection fraction and recurrent ventricular tachycardia. The role of implantable cardioverter defibrillator and selective ablation]. Przybylski A; Derejko P; Iwanek M; Urbanek P; Kepski R; Grzybowski J; Chojnowska L; Szumowski Ł; Szwed H; Walczak F Kardiol Pol; 2006 Jul; 64(7):758-62. PubMed ID: 16886137 [TBL] [Abstract][Full Text] [Related]
20. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device. Francisco GM; Sharma S; Dougherty AH; Kantharia BK Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]